Rare diseases
Investigational molecules
Locations
Back to Portugal498 clinical trials in Porto, Portugal across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Efficacy and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Face and Neck Atopic Dermatitis
PortugalStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
PortugalStudy on Rocatinlimab for Adolescents Aged 12-17 with Moderate-to-Severe Atopic Dermatitis
PortugalPortugalA Randomized, Double‑Blind, Placebo‑Controlled Study of Momelotinib Dihydrochloride Monohydrate in Patients with VEXAS Syndrome
PortugalA Phase 2a/b Study of DDY391 to Evaluate Efficacy, Safety and Tolerability in Adults with Sjögren's Disease
PortugalPhase 3 Study of Pridopidine Hydrochloride for Safety and Efficacy in Adults with Huntington’s Disease
PortugalSafety and efficacy of GS-3242 drug combination compared with standard drug combination in treatment‑naive adults with HIV‑1
PortugalEfficacy and Safety of DNTH103 in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study
PortugalStudy of subcutaneous anifrolumab pharmacokinetics, pharmacodynamics and safety in children aged 5 to <18 years with systemic lupus erythematosus
PortugalStudy of GSK5733584 versus paclitaxel or doxorubicin in patients with advanced or recurrent endometrial cancer after platinum‑based chemotherapy and immunotherapy
PortugalRandomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on polypoidal choroidal vasculopathy and rare genetic conditions like PMM2-CDG, exploring new treatment approaches to improve patient outcomes.
Groundbreaking studies in chronic myelogenous leukemia, multiple myeloma, and advanced malignancies, including research on novel therapies for non-small cell lung cancer.
Comprehensive research into conditions like hidradenitis suppurativa, plaque psoriasis, and pyoderma gangrenosum, evaluating new therapeutic approaches.
Studies examining hypertrophic cardiomyopathy, familial hypercholesterolemia, and innovative treatments for obesity.
Investigating treatments for Dravet Syndrome, menstrual migraine, and rare conditions like Niemann-Pick disease.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
